Best in Biotech 30 Mar 2020 10 Unusual Applications of CRISPR Gene Editing CRISPR has been all over the news in the past couple of years, and with reason. This gene editing tool is making gene editing easier and faster than ever, and the possibilities it has opened up go well beyond human health. You might have heard of the tremendous potential CRISPR could have in treating disease. […] March 30, 2020 - 8 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 3 Mar 2020 How Immunotherapy Could Stop and Prevent Type 1 Diabetes People with type 1 diabetes need lifelong treatments of daily insulin injections to manage their condition that still leave them at risk of long-term complications. Immunotherapy could one day become an insulin-free alternative to stop, prevent, and potentially cure this chronic disease. Type 1 diabetes is an autoimmune disease where the insulin-producing beta cells in […] March 3, 2020 - 8 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 25 Feb 2020 Biotechnology Is Changing How We Make Clothes The fashion industry is seeing the beginnings of a biotechnological revolution: using biology to make clothing to make textiles better and more sustainable. Biotechnology already plays an important role in the textile industry. Enzymes are used routinely to wash and bleach textiles, to give jeans a denim look or to prevent wool from shrinking. A […] February 25, 2020 - 7 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Expert Advice 27 Jan 2020 Five Reasons Why Biotech Startups Fail: How to Avoid Them Biotech startups are a high-risk venture and many do not reach the final line. Experts explain what the most common reasons for failure are and what can be done to avoid them. You might have heard that only 10% of startups make it. Well, biotech startups can have it even harder. Unlike the typical tech […] January 27, 2020 - 9 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 24 Jan 2020 Broad Institute Loses Appeal on European CRISPR Patent A decision from the Boards of Appeal at the European Patent Office has revoked the claim of the Broad Institute to general patents on CRISPR/Cas9 gene editing technology, strengthening the position of its opponent UC Berkeley in Europe. The Broad Institute in Cambridge, US, is one of the main contenders in the ongoing battle for […] January 24, 2020 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 21 Jan 2020 German Biotech Raises €11M to Regenerate Liver Damage Biotech company HepaRegeniX has raised a Series B round that will allow its first candidate drug for liver disease to enter clinical trials later this year. Based in Tübingen, Germany, HepaRegenix was founded in 2017 with a €9M Series A round. The same investors are now taking part in a Series B round […] January 21, 2020 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 14 Jan 2020 What’s the Secret to Making Returns in Industrial Biotech? As industrial biotech starts gaining more and more traction, investors need to change their mindset in order to start making returns in this promising field. Microorganisms have been helping us make food and drink since ancient times. Thanks to the industrial biotech revolution, these microbes could soon be responsible for manufacturing anything from clothing to […] January 14, 2020 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 3 Jan 2020 Update: CARB-X Grants Antabio Additional €4M to Develop Cystic Fibrosis Antibiotic Update (03/01/2020): The global non-profit partnership CARB-X has awarded Antabio €4M ($4.4M) as a second grant installment funding development of a novel antibiotic for use against Pseudomonas infections in patients with cystic fibrosis. This is the second installment of a grant worth up to €7.6M awarded to Antabio in 2017. The French biotech was awarded […] January 3, 2020 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 20 Dec 2019 German Startup Raises €4M Seed Round to Make Dairy Cheese Without Milk Berlin-based startup Legendairy Foods has raised €4M to develop cheese and other dairy products that have the same composition as milk but are not derived from animals. The fundraising was co-led by food tech investor Agronomics and M Ventures, the corporate venture capital arm of Merck. CPT Capital, an investor in alternative proteins, […] December 20, 2019 - 1 minutemin - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
More News! 18 Dec 2019 French Biotech Raises €20M to Treat Cannabis Addiction Without Side Effects Bordeaux-based Aelis Farma will use €20M in fresh funding to develop a new treatment for cannabis addiction and cannabis-induced psychosis, as well as a therapy for cognitive deficits in Down’s syndrome. The funding consists of €11M from a financing round coming mostly from regional investors, in addition to €9M raised through research grants. The […] December 18, 2019 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
More News! 10 Dec 2019 After Phase III Failure, UK Firm Pushes Placebo to Treat Erectile Dysfunction The strong placebo effect seen in Futura Medical’s phase III trial in erectile dysfunction has not deterred the company, but has instead encouraged it to seek approval for its medical device delivering the placebo rather than the drug as originally intended. Based in Surrey, UK, Futura Medical is developing a medical device used […] December 10, 2019 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 9 Dec 2019 Autolus Reveals Early Clinical Data of Next-Gen CAR-T Therapy London-based Autolus has shown its next-generation CAR T-cell therapy does not induce some of the severe side effects that have led to deaths in patients treated with CAR T-cell treatments currently on the market. Since their arrival on the market in 2017, CAR T-cell therapies have provided hope to patients with rare forms of blood […] December 9, 2019 - 4 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email